Gastroenterology Month in Review: February 2025

Name: Long-Term VIVID-2 Data for Mirikizumab in Crohn’s Disease, with Edward Barnes, MD, MPH
Uploaded: 2025-03-05T11:00:00Z
Duration: 4 min 55 s
Description: Long-Term VIVID-2 Data for Mirikizumab in Crohn’s Disease, with Edward Barnes, MD, MPH

Author(s)Abigail Brooks, MA

The gastroenterology month in review spotlights GI FDA news, research about colorectal cancer and alcohol complications, and new data for mirikizumab.

February delivered a robust slate of advancements in gastroenterology, characterized by notable drug developments and pivotal clinical research.